Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

NASDAQ:PCRX

Pacira BioSciences, Inc.

Last Close

25.90

25/04 20:00

Market Cap

1.19B

Beta: 0.76

Volume Today

288.93K

Avg: 596.19K

PE Ratio

207.02

PFCF: 11.04

Please Sign In To Use The Chat